  The group of acquired myasthenias are autoimmune diseases, however they have different pathogenesis. Exact classification (clinical and histological) is important for planing and evaluation of therapeutic effects, especially thymectomy and thymomectomy. In the longterm therapy of MG patients many problems could be avoided by the knowledge of clinical characteristics (e.g. accompanying illness, medication, vaccination). Other important aspects are the psychological and social situation of the patient after diagnosis and during therapy. Rehabilitation should be initiated early to enable the patient for working in his old profession if possible. The patient and attending doctors should be informed to avoid deterioration of MG and treatment of myasthenic crisis.  
